Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Further interim data presented from phase Ib study of EDP-1815 in patients with psoriasis

Nov. 6, 2019

Clinical development of MOR-106 for atopic dermatitis ended for futility

Oct. 29, 2019

BioCryst Pharmaceuticals discloses complement factor D inhibitors

Oct. 29, 2019

Microbion announces phase Ib data for pravibismane in infected diabetic foot ulcers

Oct. 29, 2019

First subject dosed in phase II ADVISE study of etrasimod in atopic dermatitis

Oct. 29, 2019

Arcutis plans phase III program with ARQ-151 for plaque psoriasis

Oct. 28, 2019

Rapt Therapeutics studies oral CCR4 antagonist RPT-193 in first-in-human trial

Oct. 24, 2019

Ex vivo gene-corrected autologous cell therapy for chronic RDEB wounds: results of phase I/IIa trial

Oct. 24, 2019

FDA grants approval to Amzeeq topical foam for acne

Oct. 21, 2019

Phase III BE VIVID study of bimekizumab in psoriasis meets all endpoints

Oct. 18, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...